1ACY image
Deposition Date 1994-02-10
Release Date 1994-07-31
Last Version Date 2024-10-16
Entry Detail
PDB ID:
1ACY
Title:
CRYSTAL STRUCTURE OF THE PRINCIPAL NEUTRALIZING SITE OF HIV-1
Biological Source:
Source Organism:
Mus musculus (Taxon ID: 10090)
HIV-1 M:B_MN (Taxon ID: 11696)
Method Details:
Experimental Method:
Resolution:
3.00 Å
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:IGG1-KAPPA 59.1 FAB (HEAVY CHAIN)
Gene (Uniprot):Ighg1
Chain IDs:B (auth: H)
Chain Length:221
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:IGG1-KAPPA 59.1 FAB (LIGHT CHAIN)
Chain IDs:A (auth: L)
Chain Length:215
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:HIV-1 GP120 (MN ISOLATE)
Gene (Uniprot):env
Chain IDs:C (auth: P)
Chain Length:24
Number of Molecules:1
Biological Source:HIV-1 M:B_MN
Ligand Molecules
Primary Citation
Crystal structure of the principal neutralization site of HIV-1.
Science 264 82 85 (1994)
PMID: 7511253

Abstact

The crystal structure of a complex between a 24-amino acid peptide from the third variable (V3) loop of human immunodeficiency virus-type 1 (HIV-1) gp 120 and the Fab fragment of a broadly neutralizing antibody (59.1) was determined to 3 angstrom resolution. The tip of the V3 loop containing the Gly-Pro-Gly-Arg-Ala-Phe sequence adopts a double-turn conformation, which may be the basis of its conservation in many HIV-1 isolates. A complete map of the HIV-1 principal neutralizing determinant was constructed by stitching together structures of V3 loop peptides bound to 59.1 and to an isolate-specific (MN) neutralizing antibody (50.1). Structural conservation of the overlapping epitopes suggests that this biologically relevant conformation could be of use in the design of synthetic vaccines and drugs to inhibit HIV-1 entry and virus-related cellular fusion.

Legend

Protein

Chemical

Disease

Primary Citation of related structures